With so much controversy surrounding the American Board of Medical Specialties' Maintenance of Certification program in 2015, especially as it pertained to the ABIM, Dr. Westby Fisher recaps some of the earlier announcements about the ABMS MOC program, then summarizes the year's most pertinent developments to serve as a springboard for 2016.
A patient recently asked me, “What do you think it’s like to have RA” and “How would you describe it to someone you just met?” Could I walk a mile in her shoes? Here's my version and theirs.
Was 2015 a good year for psoriasis, IL-17, biosimilars, narcotics, the ACR and gout? Our year end review discusses the most impactful news and research from the last 12 months.
I find it interesting that when the Q&A part of the lecture begins, everyone acts as if they just got on the elevator. Who is willing to go out on a limb and ask the first question? Is Q&A the best or worst part of lectures that you attend? What can you do change the impact of your next Q&A experience?
Getting the right drug to the right patient isn’t quite as easy as it should be. Here's a collection of appeal trench war musings and tactics with a sample letter for all to use.
Are you efficient, productive and accurate in what you do? Could you be better? Or do the job differently?
Hospital consults – “nobody goes there anymore”, and not because it’s too crowded (a quote from the late great Yogi Berra), but rather because it’s a poor investment of time and resources.
Discussions on drug safety can be as treacherous as quicksand for the patient and physician. What the physician knows and what the patient perceives may not be in sync.
Use your ICD-9 codes today and tomorrow 9/30/15, and then use ICD-10 codes only on 10/1/15 and thereafter. Do not submit both ICD-9 and ICD-10 codes on any day as these will be rejected by CMS.
Many rheumatologists need to go through the recertification process. The ABIM handling of this "requirement" has generated heated discussions over what appears to be an expensive, onerous, and irrelevant effort.
The 4th annual IFPA meeting was held in Stockholm, Sweden on July 9-11, 2015. Leading experts discussed advances in research, therapy and patient care for psoriasis and psoriatic arthritis.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
